Scarica l'app Stockscreener
0.4993
15.34%
-0.0905
Precedente Chiudi:
$0.5898
Aprire:
$0.56
Volume 24 ore:
1.08M
Relative Volume:
1.41
Capitalizzazione di mercato:
$27.71M
Reddito:
-
Utile/perdita netta:
$-20.23M
Rapporto P/E:
-0.8888
EPS:
-0.5618
Flusso di cassa netto:
$-13.97M
1 W Prestazione:
-4.66%
1M Prestazione:
-10.97%
6M Prestazione:
-62.46%
1 anno Prestazione:
-55.02%
Intervallo 1D:
$0.4913
$0.585
Intervallo di 1 settimana:
$0.4913
$0.6278
Portata 52W:
$0.4813
$4.00
Heartbeam Inc Stock (BEAT) Company Profile
Nome
Heartbeam Inc
Settore
Industria
Telefono
408-899-4443
Indirizzo
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT vs VEEV, BTSG, TEM, HQY, TXG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
0.4993 | 31.75M | 0 | -20.23M | -13.97M | -0.5618 |
VEEV
Veeva Systems Inc
|
243.75 | 39.23B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
61.71 | 11.81B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.10 | 9.85B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
104.73 | 8.82B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
56.09 | 7.52B | 638.78M | -22.66M | 122.18M | -0.1744 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-20 | Downgrade | D. Boral Capital | Buy → Hold |
| 2026-03-31 | Iniziato | B. Riley Securities | Buy |
| 2026-03-27 | Iniziato | D. Boral Capital | Buy |
| 2026-03-16 | Downgrade | The Benchmark Company | Buy → Speculative Buy |
| 2025-12-11 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2025-12-08 | Iniziato | H.C. Wainwright | Buy |
| 2025-10-31 | Iniziato | Roth Capital | Buy |
| 2020-09-11 | Iniziato | Needham | Buy |
| 2020-09-02 | Iniziato | Robert W. Baird | Neutral |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-08-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | Reiterato | Dougherty & Company | Buy |
| 2018-07-26 | Reiterato | Lake Street | Buy |
| 2018-04-26 | Reiterato | The Benchmark Company | Buy |
| 2018-02-23 | Reiterato | Dougherty & Company | Buy |
| 2017-11-08 | Reiterato | Dougherty & Company | Buy |
| 2017-10-26 | Iniziato | Raymond James | Outperform |
| 2017-10-24 | Iniziato | SunTrust | Buy |
| 2017-08-09 | Reiterato | Dougherty & Company | Buy |
| 2017-07-19 | Reiterato | The Benchmark Company | Buy |
| 2017-04-11 | Reiterato | Dougherty & Company | Buy |
| 2016-12-02 | Iniziato | Dougherty & Company | Buy |
| 2016-09-13 | Iniziato | Sidoti | Buy |
| 2016-08-03 | Reiterato | The Benchmark Company | Buy |
| 2015-07-28 | Reiterato | Dougherty & Company | Buy |
| 2013-10-24 | Iniziato | The Benchmark Company | Buy |
| 2013-08-21 | Iniziato | Dougherty & Company | Buy |
Mostra tutto
Heartbeam Inc Borsa (BEAT) Ultime notizie
HeartBeam enters $25 million at-the-market equity sales agreement with Titan Partners - Investing.com Canada
Heartbeam, Inc. Enters Into At-The-Market Equity Offering Sales Agreement For Up To $25 Million In Common Stock - TradingView
Form 8K Heartbeam Inc For: 14 August By Investing.com - Investing.com India
Medical Journal Article Highlights Technology’s Potential to Detect Heart Attack Risk at Home - Medical Product Outsourcing
HeartBeam Inc (BEAT) (Q2 2026) Earnings Call Highlights: FDA Submission Advances and Commercial ... - Investing.com Canada
Heartbeam earnings missed by $1.01, revenue fell short of estimates - Investing.com Canada
HeartBeam Q2 slides show clinical progress despite wider Q2 2026 loss By Investing.com - Investing.com Australia
HeartBeam Q2 slides show clinical progress despite wider Q2 2026 loss - Investing.com
Why is Heartbeam stock sliding today? By Investing.com - Investing.com India
Earnings call transcript: HeartBeam posts wider Q2 2026 loss, stock slips after hours - Investing.com
BEAT: FDA pre-submission for heart attack detection and commercial rollout drive growth, with costs down - TradingView
HeartBeam Q2 Results: Net loss narrows to $5M, cash burn down 7% - scanx.trade
BEAT: FDA pre-submission completed, commercial rollout expands, and cash runway extended into 2027 - TradingView
HeartBeam Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Why is Heartbeam stock sliding today? - Investing.com
HeartBeam, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:BEAT) 2026-08-13 - Seeking Alpha
HeartBeam, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
HeartBeam (BEAT): Strome group details 6.8% ownership and July–August share sales - Stock Titan
HeartBeam posts wider Q2 loss than expected, shares inch lower By Investing.com - Investing.com South Africa
HeartBeam Q2 2026 results: Cash-burn outlook improves as net loss holds near $5 million - tradingkey.com
HeartBeam (NASDAQ: BEAT) details Q2 loss, $11.5M equity raise and Nasdaq risk - Stock Titan
HeartBeam, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
HeartBeam Reports Second Quarter 2026 Results - Business Wire
HeartBeam Inc (BEAT) Q2 2026 Earnings Report Preview: What To Look For - Yahoo Finance
HeartBeam Inc (BEAT) Q2 2026 Earnings Report Preview: What To Lo - GuruFocus
Heartbeam Inc (BEAT) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Earnings Preview: HeartBeam to Report Financial Results Post-market on August 13 - Moomoo
HeartBeam, Inc. (BEATW) Analyst insights, Price targets and Recommendations - Yahoo Finance Australia
Enterprise value to EBIT forward of Heartbeam, Inc. – NASDAQ:BEATW - TradingView
Price to sales forward of Heartbeam, Inc. – NASDAQ:BEATW - TradingView
Heartbeam Inc (BEAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - tradingkey.com
$HeartBeam (BEAT.US)$ - Moomoo
Heartbeam Inc (BEAT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Heartbeam Inc (BEAT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Heartbeam Inc (BEAT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Heartbeam Inc (BEAT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BEAT|Heartbeam Inc|Price:0.584|Chg%:+0.012 - tradingkey.com
Heartbeam Inc (BEAT) Institutional Confidence - TradingKey
BEAT|Heartbeam Inc|Price:0.501|Chg%:-0.017 - TradingKey
Heartbeam Inc (BEAT) Balance Sheet - TradingKey
BEAT|Heartbeam Inc|Price:0.512| - TradingKey
Heartbeam Inc (BEAT) Income Statement - TradingKey
Heartbeam Inc (BEAT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Heartbeam Inc. (BEAT) Q1 2026 Earnings: EPS Beats Estimates but Stock Declines Amid Revenue Uncertainty - dars.gov.et
Heartbeam Inc (BEAT) Cash Flow - TradingKey
Form 4 Heartbeam Inc For: 25 July By Investing.com - Investing.com South Africa
HeartBeam (NASDAQ: BEAT) CTO receives 105,740 shares in bonus grant - Stock Titan
HeartBeam, Inc. (BEAT) awards 167,760 RSUs to CFO as 2025 bonus - Stock Titan
HeartBeam, Inc. (BEAT) Grants 2,800,000 PRSUs and RSUs to President - Stock Titan
Heartbeam, Inc. (BEAT) Q3 2022 Earnings ReportResults, Call & Slides - TipRanks
Heartbeam, Inc. (BEAT) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Heartbeam Inc Azioni (BEAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
6.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):